Silodosin inhibits prostate cancer cell growth via ELK1 inactivation and enhances the cytotoxic activity of gemcitabine

Takashi Kawahara, Ali Kadhim Aljarah, Hasanain Khaleel Shareef, Satoshi Inoue, Hiroki Ide, John D. Patterson, Eiji Kashiwagi, Bin Han, Yi Li, Yichun Zheng, Hiroshi Miyamoto

Research output: Contribution to journalArticlepeer-review

15 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Silodosin inhibits prostate cancer cell growth via ELK1 inactivation and enhances the cytotoxic activity of gemcitabine'. Together they form a unique fingerprint.

Medicine & Life Sciences